Fintel reports that on April 28, 2026, Citizens initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Market Outperform recommendation. Analyst Price Forecast Suggests 102.54% Upside As of April ...

When a loved one passes away, it can be an emotional experience. Unfortunately, handling the deceased’s finances can add to this stress. While most people know that you need to file a final tax return ...

The average one-year price target for Opus Genetics (NasdaqCM:IRD) has been revised to $9.73 / share. This is an increase of 23.44% from the prior estimate of $7.88 dated February 21, 2026. The price ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Inherited retinal dystrophy (IRD) is a group of rare eye diseases. If you have IRD, you may get blurry vision, sensitivity to light, or have trouble seeing colors. Over time, you may lose some or all ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Marguerita is a Certified Financial Planner ...

CPAs MUST EXERCISE CAUTION TO CAPTURE CORRECT income in respect of the decedent (IRD) deductions on clients’ returns. Since clients typically don’t understand the issue well enough to volunteer the ...

Most tax preparers likely have heard of an IRD deduction. But since it’s less frequently claimed than many other types of deductions, many practitioners still have some questions about when and how it ...

Opus Genetics, Inc. (IRD) stock price is 4.77 and Opus Genetics, Inc. (IRD) 10-day simple moving average is 4.12. Opus Genetics, Inc. (IRD) stock price is 4.77 and Opus Genetics, Inc. (IRD) 50-day ...